Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients

Not yet recruiting

Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

Presence of one or more of seven risk factors for thromboembolic events - Prior DVT, PE, MI, CVA, coronary artery stent placement, CABG, or prothrombotic condition (Factor V Leiden deficiency, protein C deficiency, antiphospholipid syndrome, etc).

Exclusion Criteria

Simultaneous bilateral, hip resurfacing, partial knee, and revision arthroplasties